title: Potential urine and serum biomarkers for patients with bladder pain syndrome/interstitial cystitis.
abstract: There is a lack of consensus on the pathophysiology of bladder pain syndrome/interstitial cystitis. The chronic pain symptoms of bladder pain syndrome/interstitial cystitis refractory to local treatment could be a result of central nervous system sensitization and persisting abnormalities in the bladder wall, which activate the afferent sensory system. Evidence also shows that bladder pain syndrome/interstitial cystitis is a heterogeneous syndrome and that the two subtypes, the ulcerative (classic) and non-ulcerative types, represent different disease entities. There is a need for non-invasive markers for the differential diagnoses of the subtypes of bladder pain syndrome/interstitial cystitis, and between bladder pain syndrome/interstitial cystitis and bladder sensory disorders, such as hypersensitive bladder syndrome or overactive bladder. Bladder pain syndrome/interstitial cystitis, but not overactive bladder, involves an aberrant differentiation program in the bladder urothelium that leads to altered synthesis of several proteoglycans, cell adhesion and tight junction proteins, and bacterial defense molecules. These findings have led to the rationale for identifying urinary biomarkers to detect bladder pain syndrome/interstitial cystitis in patients with frequency urgency syndrome. Recently, the markers that have been the focus of the most research are antiproliferative factor, epidermal growth factor, heparin-binding epidermal growth factor, glycosaminoglycans and bladder nitric oxide. In addition, inflammatory proteins in the urine and serum play important roles in the pathogenesis of bladder pain syndrome/interstitial cystitis. The urinary proteome is an easily accessible source of biomarkers for differentiation between inflammatory bladder disorders. Analysis of multiple urinary proteins and serum cytokines could provide a diagnostic basis for bladder pain syndrome/interstitial cystitis, and could be a tool for the differential diagnosis of bladder pain syndrome/interstitial cystitis and other sensory bladder disorders.
authors.affiliation: Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan.
authors.forename: Hann-Chorng
authors.initials: HC
authors.lastname: Kuo
mesh_terms: D015415:Biomarkers / Q000097:blood / Q000652:urine; D018856:Cystitis, Interstitial / Q000175:diagnosis / Q000378:metabolism; D016207:Cytokines / Q000097:blood*; D003937:Diagnosis, Differential; D004815:Epidermal Growth Factor / Q000652:urine*; D006023:Glycoproteins / Q000652:urine*; D006025:Glycosaminoglycans / Q000652:urine*; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins; D020543:Proteome; D001743:Urinary Bladder / Q000378:metabolism / Q000473:pathology; D019459:Urothelium / Q000378:metabolism / Q000473:pathology
chemical_list: D015415:Biomarkers; D016207:Cytokines; D006023:Glycoproteins; D006025:Glycosaminoglycans; D036341:Intercellular Signaling Peptides and Proteins; D020543:Proteome; C490708:antiproliferative factor APF, human; D004815:Epidermal Growth Factor
keywords: biomarker; chemokines; interstitial cystitis; overactive bladder; proteomics